Trial Profile
A phase II trial of bisnorcymserine (BNC) for the treatment of advanced Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Bisnorcymserine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 14 Apr 2015 New trial record